← Open Payments lookup

LINDSAY O'NEIL: Open Payments

NPI 1508113929 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,504 in 298 payments from 21 companies in 2025. Trend: 2023 $2,182 · 2024 $3,365 · 2025 $4,504

Food & beverage: $4,453Education: $51
CompanyPaymentsAmount
Janssen Biotech, Inc.52$826
ABBVIE INC.46$683
Madrigal Pharmaceuticals41$616
GENZYME CORPORATION17$348
Salix Pharmaceuticals, a division of Bausch Health US, LLC13$276
Gilead Sciences, Inc.18$276
Takeda Pharmaceuticals U.S.A., Inc.11$246
Phathom Pharmaceuticals, Inc.28$239
Lilly USA, LLC13$209
Ardelyx, Inc.25$200

Products named: TREMFYA, REZDIFFRA, DUPIXENT, RINVOQ, XIFAXAN, VOQUEZNA, OMVOH, IBSRELA.

Industry payments across NE — which companies pay providers there.